SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?


To: Claud B who wrote (5409)8/30/1998 11:45:00 AM
From: Linda Kaplan  Read Replies (1) | Respond to of 7041
 
Lots of stocks trade below cash in back and below book value, especially if their future is grim, there are law suits against ZONA that might deplete their cash quickly, and if their drug is useless and may be rejected by the FDA, more reasons for a stock to trade below cash or book.

It's not what you think as fair on which I operate; it's what I think as fair. :-)

Linda